Nuvo Research, a specialty pharmaceutical company specializing in topical pain treatments, announced it received FDA approval for a supplemental new drug application, according to The Sacramento Bee.
The FDA approved Pliaglis, a topical local anesthetic cream that forms a pliable peel on the skin when exposed to air. The cream is intended for use on intact skin to provide local analgesia for aesthetic procedures, such as dermal filler injections, facial laser resurfacing and laser-assisted tattoo removal.
More Articles on Anesthesia:
Checklist for F1RSTUse Platform Released by Anesthesia Business Consultants
Accutron's Ultra PC Flowmeter Sedation System Recalled by FDA
Oximetry Incorporated Into EarlySense's Bedside Patient Monitoring System
The FDA approved Pliaglis, a topical local anesthetic cream that forms a pliable peel on the skin when exposed to air. The cream is intended for use on intact skin to provide local analgesia for aesthetic procedures, such as dermal filler injections, facial laser resurfacing and laser-assisted tattoo removal.
More Articles on Anesthesia:
Checklist for F1RSTUse Platform Released by Anesthesia Business Consultants
Accutron's Ultra PC Flowmeter Sedation System Recalled by FDA
Oximetry Incorporated Into EarlySense's Bedside Patient Monitoring System